{"id":484035,"date":"2021-04-29T07:05:15","date_gmt":"2021-04-29T11:05:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/"},"modified":"2021-04-29T07:05:15","modified_gmt":"2021-04-29T11:05:15","slug":"trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/","title":{"rendered":"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CHESTERBROOK, Pa., April  29, 2021  (GLOBE NEWSWIRE) &#8212; Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Mark A. Demitrack, M.D., Senior Vice President and Chief Medical Officer, will be participating at the 4th Annual Sachs Associates Neuroscience Innovation Forum taking place from Wednesday, April 28 to Friday, April 30, 2021.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em><br \/>\n            <u>Presentation Details<\/u><br \/>\n          <\/em><br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:600;border-collapse:collapse\">\n<tr>\n<td>Format:<\/td>\n<td>Pain, Migraine &amp; Addiction Panel<\/td>\n<\/tr>\n<tr>\n<td>Date:<\/td>\n<td>Thursday, April 29, 2021<\/td>\n<\/tr>\n<tr>\n<td>Time:\u00a0<\/td>\n<td>11:50 a.m. Eastern Time<\/td>\n<\/tr>\n<tr>\n<td>Presenter:\u00a0<\/td>\n<td>Mark Demitrack, <em>Senior Vice President and Chief <\/em><em>Medical <\/em><em>Officer<\/em><\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">Trevena\u2019s panel discussion will be available on demand during the conference to registered participants.<\/p>\n<p align=\"justify\">\n        <strong>About Trevena<\/strong>\n      <\/p>\n<p align=\"justify\">Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK\u2122 (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company\u2019s novel pipeline is based on Nobel Prize winning research and includes four differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, TRV045 for epilepsy and chronic neuropathic pain, and TRV027 for acute respiratory distress syndrome and abnormal blood clotting in COVID-19 patients.<\/p>\n<p align=\"justify\">For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=riuucIB2fYb_4A030HovWm_0XAPzsS4rJo1Jk8GX55IT729vQw76AsDnVAlx3yA1akNdpRgfK1oRWfnuC2WOuw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.Trevena.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Daniel Ferry<br \/>Managing Director<br \/>LifeSci Advisors<br \/>daniel@lifesciadvisors.com<br \/>(617) 430-7576<\/p>\n<p align=\"justify\">\n        <strong>PR &amp; Media Contact:<\/strong><br \/>\n        <br \/>Sasha Bennett<br \/>Director<br \/>Clyde Group<br \/>Sasha.Bennett@clydegroup.com<br \/>(239) 248-3409<\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/425cdc75-df62-4802-a3af-d4ed627b5688\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHESTERBROOK, Pa., April 29, 2021 (GLOBE NEWSWIRE) &#8212; Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Mark A. Demitrack, M.D., Senior Vice President and Chief Medical Officer, will be participating at the 4th Annual Sachs Associates Neuroscience Innovation Forum taking place from Wednesday, April 28 to Friday, April 30, 2021. Presentation Details Format: Pain, Migraine &amp; Addiction Panel Date: Thursday, April 29, 2021 Time:\u00a0 11:50 a.m. Eastern Time Presenter:\u00a0 Mark Demitrack, Senior Vice President and Chief Medical Officer Trevena\u2019s panel discussion will be available on demand during the conference to registered participants. About Trevena Trevena, Inc. is a biopharmaceutical company focused on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484035","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHESTERBROOK, Pa., April 29, 2021 (GLOBE NEWSWIRE) &#8212; Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Mark A. Demitrack, M.D., Senior Vice President and Chief Medical Officer, will be participating at the 4th Annual Sachs Associates Neuroscience Innovation Forum taking place from Wednesday, April 28 to Friday, April 30, 2021. Presentation Details Format: Pain, Migraine &amp; Addiction Panel Date: Thursday, April 29, 2021 Time:\u00a0 11:50 a.m. Eastern Time Presenter:\u00a0 Mark Demitrack, Senior Vice President and Chief Medical Officer Trevena\u2019s panel discussion will be available on demand during the conference to registered participants. About Trevena Trevena, Inc. is a biopharmaceutical company focused on &hellip; Continue reading &quot;Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T11:05:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum\",\"datePublished\":\"2021-04-29T11:05:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/\"},\"wordCount\":260,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/\",\"name\":\"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=\",\"datePublished\":\"2021-04-29T11:05:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/","og_locale":"en_US","og_type":"article","og_title":"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum - Market Newsdesk","og_description":"CHESTERBROOK, Pa., April 29, 2021 (GLOBE NEWSWIRE) &#8212; Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Mark A. Demitrack, M.D., Senior Vice President and Chief Medical Officer, will be participating at the 4th Annual Sachs Associates Neuroscience Innovation Forum taking place from Wednesday, April 28 to Friday, April 30, 2021. Presentation Details Format: Pain, Migraine &amp; Addiction Panel Date: Thursday, April 29, 2021 Time:\u00a0 11:50 a.m. Eastern Time Presenter:\u00a0 Mark Demitrack, Senior Vice President and Chief Medical Officer Trevena\u2019s panel discussion will be available on demand during the conference to registered participants. About Trevena Trevena, Inc. is a biopharmaceutical company focused on &hellip; Continue reading \"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T11:05:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum","datePublished":"2021-04-29T11:05:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/"},"wordCount":260,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/","name":"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=","datePublished":"2021-04-29T11:05:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk5NCM0MTQ1NDI1IzIwMDUwMzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-at-the-sachs-associates-4th-annual-neuroscience-innovation-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484035"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484035\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}